Home > Insider Trading > Filing (0001493152-21-032039)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1873835	Immix Biopharma Inc.	IMMX	Pharmaceutical Preparations (2834)	454869378

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1895035	Jason Hsu	C/O Immix Biopharma, Inc. 11400 West Olympic Blvd., Suite 200 Los Angeles CA 90064		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2021-12-20	3,915,913	$0.85	3,915,913	No	4	C	Indirect	See Footnote
Common Stock	Acquisiton	2021-12-20	50,000	$5.00	50,000	No	4	P	Indirect	See Footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	See Footnote
No	4	P	Indirect	See Footnote

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Convertible Note	Disposition	2021-12-20	0	$0.00	3,915,913	$0.85

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	C	Indirect

Footnotes

Jason Hsu is the Sole Member of VERITAS LIBERABIT VOS, LLC ("VL") and in such capacity has the right to vote and dispose of the securities held by such entity.
Jason Hsu is the Sole Member of Signature Collection Properties, LLC and in such capacity has the right to vote and dispose of the securities held by such entity.
On September 1, 2016, the Registrant issued VL a note in the amount of $3 million which is payable upon request of the majority holders of like tenure notes on or after March 31, 2022. Pursuant to the terms of the note, because the Registrant sold equity securities in its initial public offering resulting in proceeds of at least $10 million, the note automatically converted into shares of the Registrant's common stock.